Manuscripts
Abstracts
October 1, 2020
Impact of Curated Data on Electronic Quality Measure Capture Rates within CancerLinQ
ASCO Quality Care Symposium 2020
Rios KC et al
October 1, 2020
Disproportionate impact of COVID-19 disease among racial and ethnic minorities in the U.S. cancer population as seen in CancerLinQ Discovery data.
ASCO Quality Care Symposium 2020
Potter D et al
March 10, 2021
Demographics, clinical characteristics, and treatment patterns for patients with BRCA mutated, HER2-negative early stage breast cancer: a CancerLinQ real-world US study [VENICE]
Miami Breast Cancer Conference 2021
Mokiou S et al
December 11, 2020
Real-world clinical outcomes of patients with BRCA-mutated (BRCAm) HER2-negative metastatic breast cancer: A CancerLinQ study (MILAN)
San Antonio Breast Cancer Symposium 2020
Miller RS et al
May 20, 2020
Low rates of BRCA1 and BRCA2 testing for patients with ovarian cancer in ASCO's CancerLinQ, a real-world database
ASCO Annual Meeting 2020
Dewdney S et al
May 20, 2020
Treatment trends with immune checkpoint inhibitor (ICI) therapy in older adults with lung cancer
ASCO Annual Meeting 2020 AM20
Walko CM et al
May 20, 2020
Development of an artificial intelligence model to dynamically predict metastatic recurrence of early-stage breast cancer patients
ASCO Annual Meeting 2020
Vaidya V et al
May 20, 2020
Development of an algorithm using natural language processing to identify metastatic breast cancer patients from clinical notes.
ASCO Annual Meeting 2020
Swaminathan K et al
May 20, 2020
Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration
ASCO Annual Meeting 2020
Rivera D et al
